Research Projects



Currentright arrow Completedright arrow


Currentright arrow Completedright arrow


Currentright arrow Completedright arrow

Self-sampling for HPV screening: a community trial

There are major ethnic inequalities in cervical cancer screening, incidence, and mortality in New Zealand. Human papillomavirus (HPV) is the main cause of cervical cancer. Screening for high-risk HPV genotypes (with appropriate subsequent treatment) could prevent nearly all instances of cervical cancer. The research team members believe offering the opportunity for self-sampling to obtain a cervical specimen for HPV testing will mean more women participate in the National Cervical Screening Programme and incidence, mortality rates and ethnic disparities in screening will be reduced. The team will conduct a community trial in Māori, Pacific and Asian women, comparing invitation for screening with invitation for self-sampling. They will determine whether non-screened and under-screened women find self-sampling acceptable and establish which factors affect their perceptions. The study aims to contribute to reducing inequities in New Zealand by exploring the use of a new cervical screening method that women, who do not currently undergo screening, may find acceptable.

July 2016


  • Dr Collette Bromhead
  • Massey University, NZ
  • Karen Bartholomew
  • Waitemata District Health Board
  • Dr Helen Wihongi
  • Waitemata District Health Board
  • Rachel Rush
  • Georgina McPherson
  • Professor Chris Cunningham
  • Massey University, NZ


  • Health Research Council of New Zealand